Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)

Active
Yes
Status
Posted
Published Date
February 21st, 2024
Close Date
July 2nd, 2024
Opportunity No.
RFA-AG-25-002

Agency

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The National Institutes of Health (NIH) has posted a grant opportunity titled "Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)". This opportunity falls under the category of Income Security and Social Services. The grant is a Cooperative Agreement and does not require cost sharing or matching. The purpose of this grant is to establish a Consortium that will provide resources, expertise, and coordination to advance innovative and high-quality research on palliative care for individuals with serious illnesses across their lifespan. The Consortium will focus on research related to Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD), cancer, and other serious illnesses and populations relevant to the partnering Institutes, Centers, and Offices (ICOs) within NIH. The goals of this initiative include generating new scientific knowledge, supporting pilot and exploratory studies, fostering the development of early- and mid-career palliative care investigators, serving as a national platform for palliative care research resources, engaging healthcare systems and community-based organizations as research partners, and disseminating research findings and best practices to the palliative care research and clinical communities. The Consortium will also focus on addressing disparities in access, quality, and use of palliative care services for health disparities populations or in underserved areas. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territories or Possessions. Non-domestic (non-U.S.) Entities (Foreign Organizations) and non-U.S. components of U.S. Organizations are not eligible to apply. The closing date for this grant opportunity is July 2, 2024. For more information and to apply, please visit the following link: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-002.html. If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.

Description

This Notice of Funding Opportunity (NOFO) invites applications for a U54 Specialized Center (henceforth: Consortium) to provide resources, expertise, and coordination to advance innovative, high-quality research on palliative care for those with serious illness across the lifespan. This research infrastructure will encompass Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD), cancer, and other serious illnesses and populations relevant to the partnering Institutes, Centers, and Offices (ICOs). NIH currently funds many palliative care research projects across the ICOs, and there is a need for a structure to leverage synergies, coordinate efforts, develop the scientific workforce, and address remaining gaps in the field. The goals of this initiative include generating new scientific knowledge, in part through supporting pilot and exploratory studies; fostering development of early- and mid-career palliative care investigators; serving as a national platform to provide research resources and facilitate high-quality palliative care research; engaging healthcare systems and community-based organizations as research partners and settings for palliative care research; and disseminating research findings, best practices, data, and other impactful resources to the palliative care research and clinical communities. An important focus of the Consortiums work will be on facilitating research to understand and address disparities in access, quality, and use of palliative care services for health disparities populations or in underserved areas.

Contact Information

Attachments
0 KB

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional)". This opportunity falls under the category of Health and is a Cooperative Agreement funding instrument type. The grant does not require cost sharing or matching. The purpose of this grant is to support renewal and competing revision applications for U01 research project cooperative agreements focused on aging research. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territory or Possession. The closing date for this grant opportunity is October 1, 2024. For more information and to apply, please visit the following link: [Additional Information](http://grants.nih.gov/grants/guide/pa-files/PAR-22-362.html). If you have any inquiries, please refer to the contact information provided in Section VII. Agency Contacts within the full opportunity announcement.